AMAG Pharma (AMAG) Tops Q2 EPS by 25c
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Financial Fact:
Total costs and expenses: 105.02M
Today's EPS Names:
ELWT, CAAP, RNW, More
Financial Fact:
Total costs and expenses: 105.02M
Today's EPS Names:
ELWT, CAAP, RNW, More
Join SI Premium – FREE
AMAG Pharma (NASDAQ: AMAG) reported Q2 EPS of $1.45, $0.25 better than the analyst estimate of $1.20. Revenue for the quarter came in at $127.4 million versus the consensus estimate of $128.52 million.
GUIDANCE:
AMAG Pharma sees FY2016 revenue of $503-553 million, versus the consensus of $533.8 million.
For earnings history and earnings-related data on AMAG Pharma (AMAG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- HSBC Upgrades Blue Star Limited (BLSTR:IN) to Buy
- Tesla to launch Cybercab in Austin this month - report
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
